Microbiological characteristics, presumptive identification, and antibiotic susceptibilities of Staphylococcus lugdunensis

Journal of Clinical Microbiology

Volumn 46, Issue 7, 2008, Pages 2393-2395

  Thean, Yen Tan ^a   Siew, Yong Ng ^a   He, Jie ^b  

^a CHANGI GENERAL HOSPITAL   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ARYL ACYLAMIDASE; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; METICILLIN; ORNITHINE DECARBOXYLASE; PENICILLIN G; PYRROLIDONYL ARYLAMIDASE; TETRACYCLINE; UNCLASSIFIED DRUG; 5 OXOPROLYL PEPTIDASE; ANTIINFECTIVE AGENT; ORNITHINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS LUGDUNENSIS; VALIDATION PROCESS; CLASSIFICATION; DRUG EFFECT; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; PENICILLIN RESISTANCE; PHYSIOLOGY; STAPHYLOCOCCUS; VALIDATION STUDY;

STAPHYLOCOCCUS LUGDUNENSIS;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; ORNITHINE; PENICILLIN RESISTANCE; PYROGLUTAMYL-PEPTIDASE I; STAPHYLOCOCCUS;

EID: 49049120564     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00740-08     Document Type: Article

References (21)

1. Bannerman, T. L. 2003. Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically, p. 384-404. In P. R. Murray, E. J. Baron, J. H. Jorgenson, M. A. Pfaller, and R. H. Yolken (eds.), Manual of clinical microbiology, 8th ed., vol. 1. American Society for Microbiology, Washington, DC.
2. Clinical Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests; approved standard. M2-A9. Clinical Laboratory Standards Institute, Wayne, PA.
3. Clinical Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. NCCLS/ CLSI M100-S15. Clinical Laboratory Standards Institute, Wayne, PA.
4. Clinical Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S17. Clinical Laboratory Standards Institute, Wayne, PA.
5. De Paulis, A. N., S. C. Predari, C. D. Chazarreta, and J. E. Santoianni. 2003. Five-test simple scheme for species-level identification of clinically significant coagulase-negative staphylococci. J. Clin. Microbiol. 41:1219-1224.
6. Ebright, J. R., N. Penugonda, and W. Brown. 2004. Clinical experience with Staphylococcus lugdunensis bacteremia: a retrospective analysis. Diagn. Microbiol. Infect. Dis. 48:17-21.
7. Greig, J. M., and M. J. Wood. 2003. Staphylococcus lugdunensis vertebral osteomyelitis. Clin. Microbiol. Infect. 9:1139-1141.
8. Harmsen, D., C. Singer, J. Rothganger, T. Tonjum, G. S. de Hoog, H. Shah, J. Albert, and M. Frosch. 2001. Diagnostics of Neisseriaceae and Moraxellaceae by ribosomal DNA sequencing: ribosomal differentiation of medical microorganisms. J. Clin. Microbiol. 39:936-942.
9. Hellbacher, C., E. Tornqvist, and B. Soderquist. 2006. Staphylococcus lugdunensis: clinical spectrum, antibiotic susceptibility, and phenotypic and genotypic patterns of 39 isolates. Clin. Microbiol. Infect. 12:43-49.
10. Hussain, Z., L. Stoakes, S. Garrow, S. Longo, V. Fitzgerald, and R. Lannigan. 2000. Rapid detection of mecA-positive and mecA-negative coagulase-negative staphylococci by an anti-penicillin binding protein 2a slide latex agglutination test. J. Clin. Microbiol. 38:2051-2054.
11. Hussain, Z., L. Stoakes, V. Massey, D. Diagre, V. Fitzgerald, S. El Sayed, and R. Lannigan. 2000. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci. J. Clin. Microbiol. 38:752-754.
12. Ieven, M., J. Verhoeven, S. R. Pattyn, and H. Goossens. 1995. Rapid and economical method for species identification of clinically significant coagulase-negative staphylococci. J. Clin. Microbiol. 33:1060-1063.
13. Mateo, M., J. R. Maestre, L. Aguilar, F. Cafini, P. Puente, P. Sanchez, L. Alou, M. J. Gimenez, and J. Prieto. 2005. Genotypic versus phenotypic characterization, with respect to susceptibility and identification, of 17 clinical isolates of Staphylococcus lugdunensis. J. Antimicrob. Chemother. 56:287-291.
14. Paterson, D. L., and N. Nuttall. 1997. Serious infections due to Staphylococcus lugdunensis. Aust. N. Z. J. Med. 27:591.
15. Schnitzler, N., R. Meilicke, G. Conrads, D. Frank, and G. Haase. 1998. Staphylococcus lugdunensis: report of a case of peritonitis and an easy-to-perform screening strategy. J. Clin. Microbiol. 36:812-813.
16. Tan, T. Y., S. Y. Ng, and W. X. Ng. 2006. Clinical significance of coagulase-negative staphylococci recovered from nonsterile sites. J. Clin. Microbiol. 44:3413-3414.
17. Tee, W. S., S. Y. Soh, R. Lin, and L. H. Loo. 2003. Staphylococcus lugdunensis carrying the mecA gene causes catheter-associated bloodstream infection in premature neonate. J. Clin. Microbiol. 41:519-520.
18. van der Mee-Marquet, N., A. Achard, L. Mereghetti, A. Danton, M. Minier, and R. Quentin. 2003. Staphylococcus lugdunensis infections: high frequency of inguinal area carriage. J. Clin. Microbiol. 41:1404-1409.
19. Van Hoovels, L., P. De Munter, J. Colaert, I. Surmont, E. Van Wijngaerden, W. E. Peetermans, and J. Verhaegen. 2005. Three cases of destructive native valve endocarditis caused by Staphylococcus lugdunensis. Eur. J. Clin. Microbiol. Infect. Dis. 24:149-152.
20. Vannuffel, P., J. Gigi, H. Ezzedine, B. Vandercam, M. Delmee, G. Wauters, and J. L. Gala. 1995. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J. Clin. Microbiol. 33:2864-2867.
21. Zbinden, R., F. Muller, F. Brun, and A. von Graevenitz. 1997. Detection of clumping factor-positive Staphylococcus lugdunensis by Staphaurex Plus. J. Microbiol. Methods 31:95-98.